Form 4: Precision BioSciences Director Geno Germano Reports Stock Purchase

Director Geno Germano of Precision BioSciences, Inc. (DTIL) reports purchasing 3,605 shares of common stock at an average price of $4.49 on December 30, 2024.

Summary

• On December 30, 2024, Geno Germano, a director of Precision BioSciences, Inc. (DTIL), purchased 3,605 shares of common stock.
• The purchase was made at a weighted average price of $4.49 per share, with individual transactions ranging from $4.25 to $4.55.
• Following the transaction, Germano directly owns 7,807 shares of Precision BioSciences common stock.
• The transaction was reported on a Form 4 filed with the Securities and Exchange Commission on January 2, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's financial health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This purchase reflects one director's individual investment decision and may or may not be indicative of broader trends or sentiment within the company or the gene editing industry.

Stakeholder Impact

• The stock purchase by a director could have a slightly positive impact on shareholder sentiment.

Key Dates